Dynamic Technology Lab’s Karyopharm Therapeutics KPTI Stock Holding History

Dynamic Technology Lab’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,253	Closed	-$34K	–	1145
2023 Q2	$34K	Buy	+1,253	New	+$54K	﹤0.01%	936
2022 Q4	–	Sell	-1,498	Closed	-$123K	–	1318
2022 Q3	$123K	Sell	1,498 -3,750	-71%	-$280K	0.01%	1005
2022 Q2	$355K	Buy	+5,248	New	+$481K	0.04%	704
2022 Q1	–	Sell	-4,070	Closed	-$392K	–	1305
2021 Q4	$392K	Buy	+4,070	New	+$406K	0.04%	700
2021 Q2	–	Sell	-4,067	Closed	-$642K	–	1328
2021 Q1	$642K	Buy	4,067 +3,271	+411%	+$689K	0.07%	442
2020 Q4	$185K	Buy	+796	New	+$184K	0.03%	851
2018 Q4	–	Sell	-1,272	Closed	-$325K	–	1143
2018 Q3	$325K	Buy	+1,272	New	+$352K	0.05%	704
2016 Q2	–	Sell	-677	Closed	-$90K	–	1019
2016 Q1	$90K	Buy	+677	New	+$74.7K	0.02%	848

Other funds holding KPTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dynamic Technology Lab's KPTI Position: Q3 2023 in Review

Dynamic Technology Lab sold out of Karyopharm Therapeutics (KPTI) in Q3 2023, closing a stake of 1,253 shares — an estimated $34K sold.

Dynamic Technology Lab first reported a position in KPTI in Q1 2016 and held it in 8 quarters. The position peaked at $642K in Q1 2021. 118 funds tracked by Wall St. Rank hold KPTI as of Q3 2023.

Dynamic Technology Lab reported no remaining Karyopharm Therapeutics position as of Q3 2023 after selling out during the quarter.
Dynamic Technology Lab sold 1,253 Karyopharm Therapeutics shares in Q3 2023, an estimated $34K.
Dynamic Technology Lab first reported a position in Karyopharm Therapeutics in Q1 2016 and held it in 8 quarters.
Dynamic Technology Lab's Karyopharm Therapeutics position peaked at $642K in Q1 2021.
118 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2023.

Based on Dynamic Technology Lab's 13F filing for Q3 2023, filed 14 Nov 2023.